Wang W, Guo X, Zhang C, Ning T, et al. Prusogliptin (DBPR108) monotherapy in treatment-naive patients with type 2 diabetes: A randomized, double-blind, active and placebo-controlled, phase 3 study. Diabetes Obes Metab 2024 Jan 15. doi: 10.1111/dom.15433.
PMID: 38221859